ClinicalTrials.Veeva

Menu

Transfusion Requirements in Cardiac Surgery III (TRICS-III)

U

Unity Health Toronto

Status

Completed

Conditions

Disorder; Heart, Functional, Postoperative, Cardiac Surgery

Treatments

Other: Liberal transfusion strategy
Other: Restrictive Transfusion Strategy

Study type

Interventional

Funder types

Other

Identifiers

NCT02042898
TRICSIII
301852 (Other Grant/Funding Number)

Details and patient eligibility

About

TRICS-III is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in high risk patients having cardiac surgery using a non-inferiority trial design.

Enrollment

5,028 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 or older
  • Planned cardiac surgery using cardiopulmonary bypass
  • Informed consent obtained
  • Preoperative European System for Cardiac Operative Risk Evaluation (EuroSCORE I) of 6 or more

Exclusion criteria

  • Patients who are unable to receive or who refuse blood products
  • Patients who are involved in a preoperative autologous pre-donation program
  • Patients who are having a heart transplant or having surgery solely for an insertion of a ventricular assist device
  • Pregnancy or lactation (a negative pregnancy test must be obtained prior to randomization for women of childbearing potential.)
  • Patients who are unable to receive or who refuse blood products

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

5,028 participants in 2 patient groups

Restrictive transfusion strategy
Active Comparator group
Description:
Restrictive transfusion strategy: patients will receive a red cell transfusion if their hemoglobin is \<75 g/L (\<7.5 g/dL;\<4.7mmol/L) intraoperatively and/or postoperatively
Treatment:
Other: Restrictive Transfusion Strategy
Liberal transfusion strategy
Active Comparator group
Description:
Liberal transfusion strategy: patients will receive a red cell transfusion if their hemoglobin concentration is \<95 g/L (\<9.5 g/dL\<5.9mmol/L) intraoperatively, or postoperatively in the intensive care unit; and/or \<85 g/L (\< 8.5 g/dL;\<5.3mmol/L) on the ward.
Treatment:
Other: Liberal transfusion strategy

Trial contacts and locations

74

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems